Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Theriva Biologics Ord Shs (TOVX)  
$0.16 0.00 (0.00%) as of 4:30 Fri 7/22


Download
   
Exchange: American Stock Exchange
Security Type: Common
Shares Out: 19,990,000
Market Cap: 3.10(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.155 - $0.155
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Synthetic Biologics is a clinical-stage company developing therapeutics designed to prevent and treat gastrointestinal (GI) diseases. Co.'s main clinical development candidates are: SYN-004 (ribaxamase) which is designed to degrade certain commonly used intravenous beta-lactam antibiotics within the GI tract to prevent microbiome damage, Clostridioides difficile infection, overgrowth of pathogenic organisms, the emergence of antimicrobial resistance and acute graft-versus-host-disease in allogeneic hematopoietic cell transplant recipients; and SYN-020, a recombinant oral formulation of the enzyme intestinal alkaline phosphatase intended to treat both local GI and systemic diseases.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 40,000 240,000
Total Buy Value $0 $0 $26,156 $159,974
Total People Bought 0 0 1 1
Total Buy Transactions 0 0 2 7
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-22 2023-11-21 2023-05-23 2022-05-23

   
Records found: 63
  Page 3 of 3  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Kanzer Steve H CEO   •       •       •   2006-11-02 4 B $0.67 $4,747,874 I/I 7,086,379 7,086,379 2.64     -
   Bisgaier Charles Phd President   •       •      –    2006-11-02 4 A $2.02 $200,190 I/I 99,104 99,104     -
   Manion Michael F President   •       •       •   2006-11-01 4 D $0.27 $655,101 D/D (2,426,300) 340,000     -
   Kanzer Steve H Chief Executive Officer   •       •      –    2006-10-31 4 B $0.00 $0 I/I 7,086,380 7,086,380 2.58     -
   Kanzer Steve H CEO   •       •       •   2006-10-31 4 B $0.00 $0 I/I 7,086,379 7,086,379 2.56     -
   Kanzer Steve H CEO   •       •       •   2006-10-31 4/A B $0.00 $0 I/I 7,086,379 7,086,379 2.56     -
   Bisgaier Charles Phd Director   –       •      –    2006-10-31 3 IO $0.00 $0 I/I 0 297,309     -
   Stergis Nicholas Director   –       •       •   2006-10-31 3 IO $0.00 $0 D/D 0 4,065,876     -
   Kanzer Steve H CEOOfficer   •       •       •   2006-10-31 3 IO $0.00 $0 I/I 0 21,259,138     -
   Manion Michael F PRES CEO   •       •       •   2006-06-30 4 A $0.01 $4,363 D/D 436,300 2,766,300     -
   Manion Michael F President   •       •       •   2006-05-31 4 B $0.01 $9,350 D/D 935,000 2,330,000 3.15     -
   Manion Michael F PRESIDENT   •       •       •   2005-09-30 4 B $0.01 $11,150 D/D 1,115,000 1,395,000 3.15     -
   Manion Michael F PresidentOfficer   •       •       •   2005-07-06 3 IO $0.00 $0 D/D 0 70,000,000     -

  63 Records found
  1  2  3    
  Page 3 of 3
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed